Biogen Inc. (Nasdaq: BIIB) today announced the successful completion of the acquisition of Apellis Pharmaceuticals, Inc.

This Research Topic is the second volume of the “Inflammation, Immunity, and Cancer: New Pathways Towards Therapeutic Innovation” Community Series. Please ...

Patients with ALS, or Lou Gehrig's disease, live an average of only three years after symptoms begin, though some can survive ...

The liver is often called a "silent organ," as it can sustain significant damage without obvious symptoms. But when injury is ...

Get our picks of what to watch out for at SLAS Europe 2026, with key highlights from the program and opportunities not to be ...